Filing Details
- Accession Number:
- 0001209191-15-041211
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-11 17:00:44
- Reporting Period:
- 2015-05-08
- Filing Date:
- 2015-05-11
- Accepted Time:
- 2015-05-11 17:00:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501756 | Avalanche Biotechnologies Inc. | AAVL | Biological Products, (No Disgnostic Substances) (2836) | 205258327 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1615096 | Daniel Steven Schwartz | C/O Avalanche Biotechnologies 1035 O'Brien Drive, Suite A Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-05-08 | 17,250 | $33.05 | 418,931 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to a 10b51 trading plan adopted by the Reporting Person.
- This transaction was executed in multiple trades in prices ranging from $32.41 to $33.62, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Billionaire Hedge Funds
